S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

AMPH Amphastar Pharmaceuticals Inc

42.46

-0.20 (-0.47%)

After Hours

Last Updated: 16:30:00

Delayed by 15 minutes

Amphastar receives FDA tentative approval for Vasopressin

To read the full story on Seeking Alpha, click here.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals (NASDAQ:AMPH)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Amphastar Pharmaceuticals Charts.

Amphastar Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 9 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)

More Amphastar Pharmaceuticals Inc News Articles

Marketing Worldwide (PK)

Bell Buckle (PK)

Yuenglings Ice Cream (PK)

RespireRx Pharmaceuticals (PK)

Moon Equity (PK)

Umbra Applied Technologies (PK)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

Global Developments (PK)

Astra Energy (QB)

Clean Vision (QB)

Voip Pal Com (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions